The Food and Drug Administration on Tuesday approved Novo Nordisk's Ozempic to treat chronic kidney disease in patients who also have Type 2 diabetes, expanding the use of the wildly popular ...

A Novo Nordisk drug for hypertension and chronic kidney disease has failed a pivotal study, a setback to the Danish pharmaceutical giant’s effort to bring patients a new therapy with potential ...

Novo Nordisk has signed up to work with Evotec on the discovery and development of chronic kidney disease (CKD) drugs. The deal comes two years after Novo Nordisk licensed a kidney disease ...

Novo Nordisk drug Ozempic ... this year that would expand the drug’s uses to include treating chronic kidney disease in type 2 diabetes patients. The trial results were expected.

The Food and Drug Administration approved Novo Nordisk's Ozempic for patients with both chronic kidney disease and diabetes, ...

"All chronic kidney disease is progressive. It's a year-on-year, relentless decline in renal function," Stephen Gough, Novo Nordisk's global chief medical officer, said in an interview, referring ...